Form D · Biotechnology
Acucela Inc
Bothell, WA · CIK 0001400482
Offering snapshot reported Sep 3, 2009 · SEC filing
- Reported sold
- $440K Offering amount: $440K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 27, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2009 | Initial | $439,603 | No comparison | 1 | SEC filing |
| May 11, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-103297
Source: Form D, filed Sep 3, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nancy Boman | Executive |
| Yoshitaka Kitao | Director |
| Peter Kresel | Director |
| Ryo Kubota | Director, Executive |
| Glen Sato | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
21720 23rd Avenue Drive Se Suite 120
Bothell, WA, 98021
Bothell, WA, 98021